Position in NBIX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$19,522,682
+$9,892,425 QoQ
Shares Held
148,191
+118.2% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $35,025,551 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (55.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
148,191 | $19,522,682 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
26,144 | $15,502,869 |
All Filings in NBIX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,522,682 | 148,191 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $9,630,257 | 67,900 | Shares | Sole | 2026-02-12 | |
| 2025-06-30 | $3,443,906 | 27,400 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $9,854,460 | 89,100 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $13,690,950 | 100,300 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $20,497,638 | 177,900 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $22,206,171 | 161,300 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $10,261,248 | 74,400 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,592,128 | 72,800 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $6,142,500 | 54,600 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $6,402,970 | 67,900 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $10,263,708 | 101,400 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,072,088 | 92,700 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,234,527 | 58,700 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,571,812 | 46,900 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $5,851,179 | 68,700 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $4,939,365 | 51,500 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,430,456 | 55,800 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,079,475 | 11,100 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,543,185 | 16,100 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $730,816 | 7,600 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,782,000 | 31,000 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $2,310,885 | 26,700 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||